Retinopathy among young adults with Diabetes Mellitus from a tertiary care setting in Sri Lanka

BMC Endocrine Disorders

Volumn 14, Issue , 2014, Pages

  Katulanda, Prasad ^a,b   Waniganayake, Yasindu C ^c   Ranasinghe, Priyanga ^a   Wijetunga, WM Udai A ^c   Jayaweera, Mahesh ^c   Wijesinghe, Nishantha P ^c   Sheriff, Rezvi ^a   Matthews, David R ^b  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MINISTRY OF HEALTH   (Sri Lanka)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Rate; Sri Lanka; Young onset diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; DIABETIC RETINOPATHY; DISEASE DURATION; EYE EXAMINATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBESITY; ONSET AGE; OPHTHALMOSCOPY; SCREENING; SLIT LAMP; SRI LANKA; TERTIARY HEALTH CARE; YOUNG ADULT;

EID: 84896710155     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-14-20     Document Type: Article

References (38)

1. Abbate M, Cravedi P, Iliev I, Remuzzi G, Ruggenenti P. Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectives. Curr Diabetes Rev 2011, 7:190-200. 10.2174/157339911795843168, 21438851.
2. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clinical Diabetes 2008, 26:77-82.
3. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
4. Viswanath K, McGavin DD. Diabetic retinopathy: clinical findings and management. Community Eye Health 2003, 16:21-24. 1705856, 17491851.
5. Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H, Fareed D, Hemraj F, Taylor HR, Tuomilehto J, Alberti KG, Zimmet PZ. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol 1998, 147:448-457. 10.1093/oxfordjournals.aje.a009470, 9525531.
6. de Fine ON, Nielsen NV, Andreasen AH. Diabetic retinopathy in newly diagnosed middle-aged and elderly diabetic patients. Prevalence and interrelationship with microalbuminuria and triglycerides. Graefes Arch Clin Exp Ophthalmol 2001, 239:664-672. 10.1007/s004170100324, 11688665.
7. Dedov I, Maslova O, Suntsov Y, Bolotskaia L, Milenkaia T, Besmertnaia L. Prevalence of diabetic retinopathy and cataract in adult patients with type 1 and type 2 diabetes in Russia. Rev Diabet Stud 2009, 6:124-129. 10.1900/RDS.2009.6.124, 2779015, 19806242.
8. Ben Hamouda H, Messaoud R, Grira S, Ayadi A, Khairallah M, Soua H, Sfar MT. Prevalence and risk factors of diabetic retinopathy in children and young adults. J Fr Ophtalmol 2001, 24:367-370.
9. Raymond NT, Varadhan L, Reynold DR, Bush K, Sankaranarayanan S, Bellary S, Barnett AH, Kumar S, O'Hare JP, Group UKADSRS Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care 2009, 32:410-415. 10.2337/dc08-1422, 2646018, 19074992, Group UKADSRS.
10. Manaviat MR, Afkhami M, Shoja MR. Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol 2004, 4:9. 10.1186/1471-2415-4-9, 459228, 15228626.
11. Jayawardena R, Ranasinghe P, Byrne NM, Soares MJ, Katulanda P, Hills AP. Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health 2012, 12:380. 10.1186/1471-2458-12-380, 3447674, 22630043.
12. Prospective UK, Diabetes Study Group UK prospective diabetes study. XII: differences between asian, afro-caribbean and white caucasian type 2 diabetic patients at diagnosis of diabetes. Diabet Med 1994, 11:670-677. Diabetes Study Group.
13. Chowdhury TA, Lasker SS. Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes. QJM 2002, 95:241-246. 10.1093/qjmed/95.4.241, 11937651.
14. Pardhan S, Gilchrist J, Mahomed I. Impact of age and duration on sight-threatening retinopathy in South Asians and Caucasians attending a diabetic clinic. Eye (Lond) 2004, 18:233-240. 10.1038/sj.eye.6700629, 15004570.
15. Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RDA, Wijeratne S, Wijesuriya M, McCarthy MI, Adler AI, Matthews DR. Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka - Sri Lanka diabetes, cardiovascular study (SLDCS). Diabet Med 2008, 25:1062-1069. 10.1111/j.1464-5491.2008.02523.x, 19183311.
16. Wijewardene K, Mohideen MR, Mendis S, Fernando DS, Kulathilaka T, Weerasekara D, Uluwitta P. Prevalence of hypertension, diabetes and obesity: baseline findings of a population based survey in four provinces in Sri Lanka. Ceylon Med J 2005, 50:62-70.
17. Fernando DJ, Siribaddana S, De S, Subasinge Z. Prevalence of retinopathy in a Sri Lankan diabetes clinic. Ceylon Med J 1993, 38:120-123.
18. Weerasuriya N, Siribaddana S, Dissanayake A, Subasinghe Z, Wariyapola D, Fernando DJ. Long-term complications in newly diagnosed Sri Lankan patients with type 2 diabetes mellitus. QJM 1998, 91:439-443. 10.1093/qjmed/91.6.439, 9709462.
19. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT, Global Diabetic Retinopathy Project G Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682. 10.1016/S0161-6420(03)00475-5, 13129861, Global Diabetic Retinopathy Project G.
20. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. 10.1161/CIRCULATIONAHA.109.192644, 19805654, International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity.
21. WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163. WHO Expert Consultation.
22. Katulanda P, Shine B, Katulanda GW, Silva A, Asfir EL, Sheriff R, Somasundaram N, Long AE, Bingley PJ, McCarthy MI, Clark A, Matthews DR. Diabetes mellitus among young adults in Sri Lanka-role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study. Diabetologia 2008, 51:1368-1374. 10.1007/s00125-008-1052-6, 18528678.
23. Mather HM, Keen H. The Southall diabetes survey: prevalence of known diabetes in asians and europeans. Br Med J (Clin Res Ed) 1985, 291:1081-1084. 10.1136/bmj.291.6502.1081, 1417018, 3931804.
24. Mather HM, Chaturvedi N, Fuller JH. Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall diabetes survey, London, UK. Diabet Med 1998, 15:53-59. 10.1002/(SICI)1096-9136(199801)15:1<53::AID-DIA521>3.0.CO;2-V, 9472864.
25. Mukhopadhyay B, Forouhi NG, Fisher BM, Kesson CM, Sattar N. A comparison of glycaemic and metabolic control over time among South Asian and European patients with Type 2 diabetes: results from follow-up in a routine diabetes clinic. Diabet Med 2006, 23:94-98. 10.1111/j.1464-5491.2005.01735.x, 16409573.
26. Rema M, Mohan V. Retinopathy at diagnosis among young Asian diabetic patients: the ASDIAB study group. Diabetes 2002, 51:A206-A207.
27. Ferris FL. How effective are treatments for diabetic retinopathy?. JAMA 1993, 269:1290-1291. 10.1001/jama.1993.03500100088034, 8437309.
28. Farley TF, Mandava N, Prall FR, Carsky C. Accuracy of primary care clinicians in screening for diabetic retinopathy using single-image retinal photography. Ann Fam Med 2008, 6:428-434. 10.1370/afm.857, 2532778, 18779547.
29. Expert Committee on the D, Classification of Diabetes M Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26 Suppl 1:S5-S20. Expert Committee on the D, Classification of Diabetes M.
30. Jayawardena MHDS, Idampitiya C, Jayawarna C, Wanigasuriya K, Thomson GA, Fernando DJS. An audit of standards of care at a Sri Lankan diabetic clinic. Diabetes Res Clin Pract 2007, 75:249-251. 10.1016/j.diabres.2006.06.030, 16956693.
31. Cruickshanks KJ, Ritter LL, Klein R, Moss SE. The association of microalbuminuria with diabetic retinopathy. The Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology 1993, 100:862-867. 10.1016/S0161-6420(93)31562-9, 8510898.
32. Moriya T, Tanaka S, Kawasaki R, Ohashi Y, Akanuma Y, Yamada N, Sone H, Yamashita H, Katayama S, Japan Diabetes Complications Study G Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan diabetes complications study. Diabetes Care 2013, 36:2803-2809. 10.2337/dc12-2327, 23620478, Japan Diabetes Complications Study G.
33. Reddy SC, Kihn YM, Nurjahan MI, Ramil A. Retinopathy in type 2 diabetic patients with microalbuminuria. Nepal J Ophthalmol 2013, 5:69-74.
34. Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001, 24:1275-1279. 10.2337/diacare.24.7.1275, 11423515.
35. Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, Kohner EM, Study EPC. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 2001, 24:284-289. 10.2337/diacare.24.2.284, 11213880.
36. Chaturvedi N, Fuller JH. Mortality risk by body weight and weight change in people with NIDDM. The WHO multinational study of vascular disease in diabetes. Diabetes Care 1995, 18:766-774. 10.2337/diacare.18.6.766, 7555501.
37. Lim LS, Tai ES, Mitchell P, Wang JJ, Tay WT, Lamoureux E, Wong TY. C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci 2010, 51:4458-4463. 10.1167/iovs.09-4939, 20805569.
38. Garg S, Davis RM. Diabetic retinopathy screening update. Clin Diabetes 2009, 27:140-145.